Monday, November 1, 2021

ROSSARI Net Profit up 27 % in Q2FY22 | FUTURE OUTLOOK

     


Rossari Biotech consolidated net profit rises 26.71% in Q2FY22

The company’s sales also increased 123.99% to Rs384.52cr in the quarter ended September 2021.


Rossari Biotech Limited (Rossari), a Speciality-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries, has announced its financial results for the quarter and half-year ended September 30, 2021.

Net profit of the company rose 26.71% to Rs26.23cr in the quarter ended September 2021 as against Rs20.70cr during the previous quarter ended September 2020.

The company’s sales also increased 123.99% to Rs384.52cr in the quarter ended September 2021 as against Rs171.67cr during the previous quarter ended September 2020.


STOCK OUTLOOK

Avoid the stock for short to mid term. 1250 can act support for short term.




Disclaimer- The information on this blog are based on my personal opinion and experience, it should not be considered professional financial investment advice and in no way it should be considered as a tip. We does not take any compensation of any kind whatsoever from any reader, user and company that are mention on this website. We are not SEBI registered financial advisor or analyst.


No comments:

Post a Comment